Newsfeeds - Spark Newswire

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

August 12, 8:09 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

2 minute read

Apyx Medical Sees FY21 Sales $40.6M-$42.6M vs $38.65M Est.

By Bill Haddad

August 12, 7:27 AM

Full Year 2021 Financial Outlook: The Company is updating financial guidance for the year ending December 31, 2021 to: Total revenue in the range of $40.6 million to $42.6 million,

APYX

1 minute read

Apyx Medical Q2 EPS $(0.12) Beats $(0.15) Estimate, Sales $11.20M Beat $8.86M Estimate

By Bill Haddad

August 12, 7:25 AM

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the

APYX

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

August 12, 4:14 AM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

August 8, 10:03 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

1 minute read

Uncategorized

ROCE Insights For Apyx Medical

By Benzinga Insights

May 26, 8:58 AM

In Q1, Apyx Medical (NASDAQ:APYX) posted sales of $8.64 million. Earnings were up 151.59%, but Apyx Medical still reported an overall loss of $4.84 million. In Q4, Apyx Medical brought in $11.46 million in sales but lost $1.92 million in earnings.

APYX

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

May 12, 8:57 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

9 minute read

Uncategorized

Earnings Scheduled For May 12, 2021

By Benzinga Insights

May 12, 4:22 AM

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.

ADMA

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

May 9, 10:20 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL